$0.630200
0.00841.35%
At Close: -
$0.649700
0.023.09%
After Hours: 4:42 PM EDT
15 minutes delayed
Comments
Loading...
Bolt Biotherapeutics (BOLT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBolt Biotherapeutics (NASDAQ:BOLT) Stock Quotes, Forecast and News Summary
Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
| Open | $0.65 |
| Close | $0.63 |
| Volume / Avg. | 116.33K / 163.92K |
| Day Range | $0.62 - $0.65 |
| 52 Wk Range | 0.61 - 1.56 |
| Market Cap | $24.86M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 46 |
| Short Interest | 0.74% |
| Days to Cover | 2.32 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Bolt Biotherapeutics Inc
Sector
Health Care
Industry
Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targete...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bolt Biotherapeutics (BOLT) stock?
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Who are Bolt Biotherapeutics (BOLT) competitors?
Other companies in Bolt Biotherapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), Palatin Techs (AMEX:PTN), Geovax Labs (NASDAQ:GOVX) and Cue Biopharma (NASDAQ:CUE).
What is the forecast, or price target, for Bolt Biotherapeutics (BOLT) stock?
Bolt Biotherapeutics has a consensus price target of $2.38.
What is the current price for Bolt Biotherapeutics (BOLT)?
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.6497 last updated September 19, 2024 at 4:42 PM EDT.
Does Bolt Biotherapeutics (BOLT) pay a dividend?
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
When is Bolt Biotherapeutics (NASDAQ:BOLT) reporting earnings?
Bolt Biotherapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Bolt Biotherapeutics (BOLT) going to split?
There is no upcoming split for Bolt Biotherapeutics.
What sector and industry does Bolt Biotherapeutics (BOLT) operate in?
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.